rs776082304
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000159.4(GCDH):c.1239C>A(p.Tyr413*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y413Y) has been classified as Likely benign.
Frequency
Consequence
NM_000159.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Myriad Women’s Health, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000159.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GCDH | TSL:1 MANE Select | c.1239C>A | p.Tyr413* | stop_gained | Exon 11 of 12 | ENSP00000222214.4 | Q92947-1 | ||
| GCDH | TSL:1 | c.1239C>A | p.Tyr413* | stop_gained | Exon 10 of 11 | ENSP00000466845.1 | Q92947-1 | ||
| GCDH | c.1239C>A | p.Tyr413* | stop_gained | Exon 11 of 13 | ENSP00000519360.1 | A0AAQ5BHD5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at